SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0000850261-19-000041
Filing Date
2019-11-22
Accepted
2019-11-22 20:03:13
Documents
9

Document Format Files

Seq Description Document Type Size
1 S-3 srnes-3nov.htm S-3 345675
2 EXHIBIT 5.1 exhibit51.htm EX-5.1 20491
3 EXHIBIT 23.1 exhibit231.htm EX-23.1 3023
4 image1.jpg GRAPHIC 8596
5 image2.jpg GRAPHIC 5804
6 image3.jpg GRAPHIC 13004
7 image4.jpg GRAPHIC 13004
8 ph1.jpg GRAPHIC 15321
9 ph2.jpg GRAPHIC 15321
  Complete submission text file 0000850261-19-000041.txt   468762
Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-234869 | Film No.: 191243085
SIC: 8731 Services-Commercial Physical & Biological Research
Office of Trade & Services